PanaTimes

Wednesday, Jul 28, 2021
TV

Macau and Hong Kong Temporarily Suspend Use of Pfizer Coronavirus Vaccine Over Packaging Defect

Macau and Hong Kong Temporarily Suspend Use of Pfizer Coronavirus Vaccine Over Packaging Defect

To date, around 400,000 people in Hong Kong and nearly 38,000 Macau residents have been inoculated with the Chinese drug Sinovac and the BioNTech/Pfizer vaccine. The development comes after the recent suspension of the AstraZeneca Vaccine in multiple European countries.
*Your email address will not be displayed on website
This article does not have any comments yet.
PanaTimes
×